TRIM58
E3 ubiquitin-protein ligase TRIM58
Also known as: BIA2, TRI58_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8NG06
- Gene
- TRIM58
- Ensembl
- ENSG00000162722
- Chromosome
- 1
- Canonical length
- 486 aa
- Protein class
- Enzymes, Predicted intracellular proteins
OverviewNCBI Gene
Predicted to enable ubiquitin protein ligase activity. Predicted to be involved in innate immune response and regulation of gene expression. Predicted to be active in cytoplasm. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
486 residues, UniProt reviewed canonical sequence.
>Q8NG06|TRIM58
1 MAWAPPGERL REDARCPVCL DFLQEPVSVD CGHSFCLRCI SEFCEKSDGA QGGVYACPQC
61 RGPFRPSGFR PNRQLAGLVE SVRRLGLGAG PGARRCARHG EDLSRFCEED EAALCWVCDA
121 GPEHRTHRTA PLQEAAGSYQ VKLQMALELM RKELEDALTQ EANVGKKTVI WKEKVEMQRQ
181 RFRLEFEKHR GFLAQEEQRQ LRRLEAEERA TLQRLRESKS RLVQQSKALK ELADELQERC
241 QRPALGLLEG VRGVLSRSKA VTRLEAENIP MELKTACCIP GRRELLRKFQ VDVKLDPATA
301 HPSLLLTADL RSVQDGEPWR DVPNNPERFD TWPCILGLQS FSSGRHYWEV LVGEGAEWGL
361 GVCQDTLPRK GETTPSPENG VWALWLLKGN EYMVLASPSV PLLQLESPRC IGIFLDYEAG
421 EISFYNVTDG SYIYTFNQLF SGLLRPYFFI CDATPLILPP TTIAGSGNWA SRDHLDPASD
481 VRDDHLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TRIM58 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.36
- Highest tissue expression
- 30 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 30 nTPM
- thyroid gland: 14 nTPM
- placenta: 5.4 nTPM
- spleen: 3.8 nTPM
- testis: 2.5 nTPM
- hypothalamus: 1.8 nTPM
Single-cell type
- platelets: 1,455 nCPM
- erythrocytes: 478 nCPM
- megakaryocytes: 124 nCPM
- hematopoietic stem cells: 79 nCPM
- megakaryocyte-erythroid progenitors: 74 nCPM
- erythrocyte progenitors: 63 nCPM
Immune cell
- memory B-cell: 0.8 nTPM
- basophil: 0.7 nTPM
- neutrophil: 0.6 nTPM
- total PBMC: 0.6 nTPM
- eosinophil: 0.3 nTPM
- NK-cell: 0.3 nTPM
Brain region
- pons: 11 nTPM
- midbrain: 11 nTPM
- hypothalamus: 8.2 nTPM
- medulla oblongata: 8.1 nTPM
- thalamus: 5.3 nTPM
- spinal cord: 4.7 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.57
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.42
- DepMap mean gene effect
- 0.14
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- innate immune response
- protein autoubiquitination
- protein polyubiquitination
- regulation of gene expression
- ubiquitin-dependent protein catabolic process
- positive regulation of erythrocyte enucleation
- regulation of nuclear migration along microtubule
Molecular functions
- dynein heavy chain binding
- dynein intermediate chain binding
- ubiquitin protein ligase activity
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- B-box-type zinc finger
- Zinc finger, RING-type
- B30.2/SPRY domain
- SPRY domain
- Butyrophylin-like, SPRY domain
- SPRY-associated
- Zinc finger, RING/FYVE/PHD-type
- Concanavalin A-like lectin/glucanase domain superfamily
- Zinc finger, RING-type, conserved site
- B30.2/SPRY domain superfamily
- Tripartite motif-containing
- SPRY domain
- B-box zinc finger
- SPRY-associated domain
- zinc finger of C3HC4-type, RING
- E3 ubiquitin-protein ligase TRIM58, PRY/SPRY domain
- E3 ubiquitin-protein ligase TRIM58, RING finger, HC subclass
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TRIM58 as an antibody target. Whether an autoantibody or antibody against TRIM58 could matter depends on whether native TRIM58 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TRIM58 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TRIM58 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...